Risk of myocardial infarction and nucleoside analogues

Lancet. 2008 Apr 26;371(9622):1391-2. doi: 10.1016/S0140-6736(08)60491-2. Epub 2008 Apr 2.

Authors

James H Stein¹, Judith S Currier

Affiliation

¹ Division of Cardiovascular Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53717, USA. jhs@medicine.wisc.edu

PMID: 18387666
DOI: 10.1016/S0140-6736(08)60491-2

No abstract available

Publication types

Comment
Randomized Controlled Trial

MeSH terms

Cohort Studies
Humans
Myocardial Infarction / chemically induced*
Nucleosides / adverse effects*
Reverse Transcriptase Inhibitors / adverse effects*
Risk Factors

Substances

Nucleosides
Reverse Transcriptase Inhibitors